Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)
Title: Editorial [Hot Topic: New Insight in Obesity and Insulin Resistance (Guest Editor: Geltrude Mingrone)]
Volume: 6 Issue: 1
Author(s): Geltrude Mingrone
Affiliation:
Export Options
About this article
Cite this article as:
Mingrone Geltrude, Editorial [Hot Topic: New Insight in Obesity and Insulin Resistance (Guest Editor: Geltrude Mingrone)], Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) 2006; 6 (1) . https://dx.doi.org/10.2174/187152206775528851
DOI https://dx.doi.org/10.2174/187152206775528851 |
Print ISSN 1871-5222 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6115 |
11
Related Articles
-
Editorial from Guest Editor (Thematic Issue: Current Approach to COPD Management: Setting a Model in Medical Therapeutics)
Current Respiratory Medicine Reviews Integrins: Novel Therapeutic Targets for Cardiovascular Diseases
Cardiovascular & Hematological Agents in Medicinal Chemistry Patent Selections
Recent Patents on Cardiovascular Drug Discovery Pulmonary Hypertension and Lung Transplantation
Current Hypertension Reviews Gene Therapy Approaches for Cardiovascular Diseases
Current Gene Therapy Tumor Angiogenesis and VEGFR-2: Mechanism, Pathways and Current Biological Therapeutic Interventions
Current Drug Metabolism The Interplay Between Asthma and Other Diseases: Role of Ca2+/cAMP Signalling
Endocrine, Metabolic & Immune Disorders - Drug Targets Mediterranean Diet and Hypertension; From the Clinical and Epidemiologic Evidences to Prevention
Current Hypertension Reviews Supplementation, Optimal Status, and Analytical Determination of Vitamin D: Where are we Standing in 2012?
Anti-Cancer Agents in Medicinal Chemistry The Postprandial State and its Influence on the Development of Atherosclerosis
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Novel Drug Targets for the Treatment of Cardiac Diseases
Current Pharmacogenomics and Personalized Medicine New Insight Into A1 Adenosine Receptors in Diabetes Treatment
Current Pharmaceutical Design Soluble Guanylate Cyclase Stimulators and Activators: Where are We and Where to Go?
Mini-Reviews in Medicinal Chemistry Antithrombotic Treatment after Atrial Fibrillation Ablation
Current Pharmaceutical Design Herbal Medicine for Slowing Aging and Cardiovascular Risk: Mechanisms and Safety
Current Vascular Pharmacology Medico-Legal Evaluation of Fatal Perinatal Asphyxia
Current Pediatric Reviews COVID-19 in People with Diabetes: Perspectives from Saudi Arabia
Current Diabetes Reviews Antiobesity Therapy: Emerging Drugs and Targets
Current Medicinal Chemistry Managing Safety Signals in Large Endpoint Trials
Current Drug Safety Diabetic Nephropathy: Causes and Managements
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)